Eleven patients with rapidly progressive herpetic retinal necrosis (RP
HRN) complicating AIDS were investigated retrospectively to study the
disease spectrum, systemic involvement, and therapy, The mean CD4 cell
count was 24/mu L. There was a characteristic disease pattern with ra
pid progression, 82% bilaterality, relative resistance to intravenous
antiviral therapy, and 70% retinal detachment. Varicella-zoster virus
was the probable cause in 10 patients (detected by polymerase chain re
action in two eyes investigated), and herpes simplex virus was the pro
bable cause in one. Cutaneous tester occurred previously in 73% but wa
s not concurrent. Seventy-three percent had central nervous system dis
ease, possibly virus-related. RPHRN may be a local herpetic recrudesce
nce in an immune-privileged site with transneural spread. Only four of
20 affected eyes retained useful vision, Poor ocular bioavailability,
retina, ischemia, acquired drug resistance, and strain pathogenicity
may underlie treatment failure. Acyclovir therapy appears relatively i
neffective. Combined intravenous and intravitreal therapy with foscarn
et and ganciclovir may be the best current management, Research advanc
es are needed urgently.